Industry Intelligence
Healthcare companies advancing community pharmacy access to respiratory vaccines, diagnostics, antivirals, telehealth, immune profiling and patient-controlled health records.
Moderna said it was ranked as a top employer in the global biopharmaceutical industry in the 2026 Science and Science Careers survey.
DataMEDS AI has established the Health Lives Here Community Respiratory Program for the Corexa Health Pharmacy Network, with an initial rollout planned at Corexa Pharmacy in Lakeland, Florida.
Cosmos Health has extended its online purchasing and recurring-delivery model to Australia, New Zealand and the broader Oceania region, using the platform behind its U.S. operations.
Lexaria Bioscience Corp. reports that its Human Pilot Study #7 is fully enrolled and that dosing is continuing on schedule across three study arms.
Jaguar Health says its family company Napo Pharmaceuticals has provided liquid oral crofelemer to an infant with GUCY2C-related intestinal failure, with reported reductions in parenteral support needs.
The latest episode features CEO Rob Berman discussing severe deep venous insufficiency, its patient population and the concept of total addressable market.
Valion Bio’s interim CEO has outlined a 30-day agenda focused on advancing the company’s biologics pipeline, developing commercial opportunities for Velocity Bioworks and assessing potential strategic arrangements for the CDMO.
Ensysce Biosciences said President James Morrison used the Family Office Summit in Dubai to present its severe pain programme and discuss potential long-term relationships with investors and partners.
Cosmos Health said preliminary nine-month 2026 revenue reached approximately $54.3 million and reaffirmed its expectation that full-year revenue will surpass $90 million, while U.S. subscriptions continued to expand.